Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated with Medium- and Long-Chain Triglycerides Based on Lean Body Weight

Author:

Tian, Shunping1,Zhang Dongsheng2,Zhou, Wei2,Tan, Chao1,Shan, Qing3,Ma, Rongrong2,Xing, Zhi2,Sui, Wei2,Zhang Zhuan2

Affiliation:

1. School of Medicine, Yangzhou University, Yangzhou, China

2. Department of Anesthesiology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China

3. Department of Geriatrics, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China

Abstract

Abstract Objective To determine the median effective dose (ED50) of prophylactic intravenous lidocaine for the prevention of propofol medium-chain triglyceride/long-chain triglyceride (MCT/LCT) emulsion injection pain. Design Prospective trial, Dixon up-and-down sequential method. Setting Operating room of a single hospital. Patients Thirty patients aged 18–65 years with American Society of Anesthesiologists (ASA) status I or II who were scheduled for elective surgery under general anesthesia (GA) were included. Interventions The initial dose of prophylactic lidocaine before propofol MCT/LCT emulsion injection was set at 0.5 mg/kg lean body weight (LBW). The lidocaine dose was adjusted according to the degree of patients’ injection pain using the Dixon up-and-down sequential method. Measurements The ED50 and 95% confidence intervals (CIs) of lidocaine were calculated using the Dixon–Massey formula. Vital signs and adverse effects were recorded. In the postanesthesia care unit (PACU), patients were asked if they recalled feeling any injection pain with visual analog scale (VAS) evaluation. Results The ED50 of lidocaine for the prevention of propofol MCT/LCT emulsion injection pain was 0.306 mg/kg LBW (95% CI, 0.262–0.357 mg/kg LBW). No adverse reactions to lidocaine occurred. In the PACU, 90.9% of patients who experienced injection pain recalled this pain (VAS score, 2.8±1.8). Conclusions Prophylactic intravenous lidocaine (0.306 mg/kg LBW) effectively prevented propofol MCT/LCT emulsion injection pain in 50% of patients scheduled for elective surgery under GA with no adverse reaction occurring.

Funder

General Project of the Jiangsu Provincial Health

Wellness Committee Fund

Medical Key Talents Training Project

Yangzhou City Health and Family Planning Commission

Publisher

Oxford University Press (OUP)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Reference41 articles.

1. Changes in concentrations of free propofol by modification of the solution;Yamakage;Anesth Analg,2005

2. Dexmedetomidine pretreatment alleviates propofol injection pain;He;Ups J Med Sci,2014

3. Etomidate-remifentanil is more suitable for monitored anesthesia care during gastroscopy in older patients than propofol-remifentanil;Shen;Med Sci Monit,2015

4. Comparison of Propofol-Lipuro with propofol mixed with lidocaine 10 mg on propofol injection pain;Kam;Anaesthesia,2004

5. Pain on injection of propofol: A comparison of methylene blue and lidocaine;Salman;J Clin Anesth,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3